1991
DOI: 10.1002/ijc.2910480323
|View full text |Cite
|
Sign up to set email alerts
|

New stable butyrate derivatives alter proliferation and differentiation in human mammary cells

Abstract: Two new butyric esters which were devised to extend the half-life of n-butyric acid in vivo, were used to study their effects on a number of phenotypic characteristics including cell morphology, cell proliferation, colony formation, cell-surface antigen and estrogen receptor expression in 3 normal immortalized cell lines and 2 carcinoma cell lines derived from the human mammary gland. When treated with butyric esters, human mammary cells acquired numerous cytoplasmic granules and vacuoles, reminiscent of secre… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
10
0
1

Year Published

1992
1992
2011
2011

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 43 publications
(12 citation statements)
references
References 27 publications
1
10
0
1
Order By: Relevance
“…Butyrate also has potent effects on a variety of other cell types, including normal and malignant mammary epithelial cells [32, 33]. However, due to its rapid in vivo metabolism, it is difficult to achieve and maintain effective serum levels even when butyrate salts are administered by continuous i.v.…”
Section: Resultsmentioning
confidence: 99%
“…Butyrate also has potent effects on a variety of other cell types, including normal and malignant mammary epithelial cells [32, 33]. However, due to its rapid in vivo metabolism, it is difficult to achieve and maintain effective serum levels even when butyrate salts are administered by continuous i.v.…”
Section: Resultsmentioning
confidence: 99%
“…It is generally considered to block cell cycle progression in G1 (25,30) but might also inhibit some cell types at a point in G2 (3). It is important to emphasize that a potential secondary inhibition in G2 would not affect the experimental strategy described above, where only the first blockage after Go would be apparent.…”
Section: Discussionmentioning
confidence: 99%
“…The effect of the combined treatments on normal tissue morbidity is largely unknown, but there would be the advantage in the case of butyrate combined with radiotherapy that the effect of the combination would largely be restricted to the volume of the tumour. An alternative approach both for the butyrate alone or for combination with other therapy, is the use of derivatives of butyrate which are less readily metabolised (Planchon et al, 1991).…”
Section: Discussionmentioning
confidence: 99%